{"nctId":"NCT00857285","briefTitle":"Olmesartan Medoxomil Versus Losartan in Patients With Hypertension","startDateStruct":{"date":"2002-05"},"conditions":["Essential Hypertension"],"count":130,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: olmesartan medoxomil"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: losartan potassium"]}],"interventions":[{"name":"olmesartan medoxomil","otherNames":[]},{"name":"losartan potassium","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diastolic BP 95 mm Hg - 114 mm Hg inclusive\n* No participation in any clinical trial for the last 3 months\n\nExclusion Criteria:\n\n* Secondary hypertension\n* Malignant hypertension\n* Severe arterial hypertension\n* Significant cardiovascular disease\n* History or clinical evidence of cerebrovascular, gastrointestinal, hematological, hepatic disease, myocardial infarction, or severe liver disorder\n* Clinical evidence of renal disease, poorly controlled diabetes, known malabsorption syndromes, psychiatric/emotional problems","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change of Sitting dBP From Baseline to Week 12","description":"The difference in the sitting diastolic blood pressure (dBP) at trough, i.e. 24Â±2 hours after drug administration, from base line to Week 12.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.80","spread":"12.50"},{"groupId":"OG001","value":"-11.60","spread":"9.46"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}}